Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Check category for Wang et al. (2022) #35

Open
miseminger opened this issue Jun 5, 2024 · 0 comments
Open

Check category for Wang et al. (2022) #35

miseminger opened this issue Jun 5, 2024 · 0 comments

Comments

@miseminger
Copy link
Collaborator

In S_pharmaceutical_effectiveness.txt:

# 4th antigenic exposure with Omicron (B.1.1.529 [BA.1])(n=29) infection increased variant specific plasma antibody and memory B cell responses as well as overall increased strain specific memory in individuals aged 22 –79 years, median age=33.5 years. Data collected 2.4 months after 3rd vaccination.
# Wang et al. (2022) https://doi.org/10.1101/2022.08.11.503601 [Preprint (BioRxiv); Now published at: https://doi.org/10.1084/jem.20221006]
A67V;D614G;D796Y;E484A;G142D;G339D;G446S;G496S;H69del;H655Y;ins214EPE;K417N;L212I;N211del;N440K;N501Y;N679K;N764K;N856K;N969K;P681H;Q493R;Q498R;Q954H;S371L;S373P;S375F;S477N;T95I;T478K;T547K;V70del;V143del;Y144del;Y145del;Y505H

# 3rd exposure to antigen by Delta (B.1.617.2) (n=24) breakthrough increases the number of memory B cells that produce antibodies with comparable potency and breadth to a 3rd mRNA vaccine dose in individuals aged 21 –63 years, median age=30 years. Data collected 5.5 months after 2nd vaccination.
# Wang et al. (2022) https://doi.org/10.1101/2022.08.11.503601 [Preprint (BioRxiv); Now published at: https://doi.org/10.1084/jem.20221006]
E484A;N501Y
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
None yet
Projects
None yet
Development

No branches or pull requests

1 participant